These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 11801550)

  • 41. Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer.
    Curia MC; Palmirotta R; Aceto G; Messerini L; Verì MC; Crognale S; Valanzano R; Ficari F; Fracasso P; Stigliano V; Tonelli F; Casale V; Guadagni F; Battista P; Mariani-Costantini R; Cama A
    Cancer Res; 1999 Aug; 59(15):3570-5. PubMed ID: 10446963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defective DNA mismatch repair in long-term (> or =3 years) survivors with pancreatic cancer.
    Maple JT; Smyrk TC; Boardman LA; Johnson RA; Thibodeau SN; Chari ST
    Pancreatology; 2005; 5(2-3):220-7; discussion 227-8. PubMed ID: 15855819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability.
    Bevilacqua RA; Simpson AJ
    Int J Cancer; 2000 Jul; 87(2):200-3. PubMed ID: 10861474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
    Catto JW; Xinarianos G; Burton JL; Meuth M; Hamdy FC
    Int J Cancer; 2003 Jul; 105(4):484-90. PubMed ID: 12712438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.
    Koinuma K; Shitoh K; Miyakura Y; Furukawa T; Yamashita Y; Ota J; Ohki R; Choi YL; Wada T; Konishi F; Nagai H; Mano H
    Int J Cancer; 2004 Jan; 108(2):237-42. PubMed ID: 14639609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma.
    Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Sakamoto A; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2003 Sep; 34(9):841-9. PubMed ID: 14562278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Origin of microsatellite instability in gastric cancer.
    Halling KC; Harper J; Moskaluk CA; Thibodeau SN; Petroni GR; Yustein AS; Tosi P; Minacci C; Roviello F; Piva P; Hamilton SR; Jackson CE; Powell SM
    Am J Pathol; 1999 Jul; 155(1):205-11. PubMed ID: 10393852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Global DNA methylation in relation to hMLH1 and hMSH2 protein immunoreactivity in sporadic human endometrial carcinomas.
    Miturski R; Postawski K; Semczuk A; Bogusiewicz M; Baranowski W; Jakowicki JA; Keith G
    Int J Mol Med; 2003 May; 11(5):569-74. PubMed ID: 12684691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High frequency of microsatellite instability in young patients with head-and-neck squamous-cell carcinoma: lack of involvement of the mismatch repair genes hMLH1 AND hMSH2.
    Wang Y; Irish J; MacMillan C; Brown D; Xuan Y; Boyington C; Gullane P; Kamel-Reid S
    Int J Cancer; 2001 Aug; 93(3):353-60. PubMed ID: 11433399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined deficiency of hMLH1, hMSH2, hMSH3 and hMSH6 is an independent prognostic factor in colorectal cancer.
    Jansson A; Arbman G; Zhang H; Sun XF
    Int J Oncol; 2003 Jan; 22(1):41-9. PubMed ID: 12469183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequent loss of hMLH1 by promoter hypermethylation leads to microsatellite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer.
    Ricciardiello L; Goel A; Mantovani V; Fiorini T; Fossi S; Chang DK; Lunedei V; Pozzato P; Zagari RM; De Luca L; Fuccio L; Martinelli GN; Roda E; Boland CR; Bazzoli F
    Cancer Res; 2003 Feb; 63(4):787-92. PubMed ID: 12591727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microsatellite instability in hereditary and sporadic breast cancers.
    Adem C; Soderberg CL; Cunningham JM; Reynolds C; Sebo TJ; Thibodeau SN; Hartmann LC; Jenkins RB
    Int J Cancer; 2003 Nov; 107(4):580-2. PubMed ID: 14520695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of microsatellite testing and mismatch repair protein expression on the clinical interpretation of genetic testing in hereditary non-polyposis colorectal cancer.
    Ward R; Meldrum C; Williams R; Mokany E; Scott R; Turner J; Hawkins N; Burgess B; Groombridge C; Spigelman A
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):403-11. PubMed ID: 12200596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers.
    Simpkins SB; Bocker T; Swisher EM; Mutch DG; Gersell DJ; Kovatich AJ; Palazzo JP; Fishel R; Goodfellow PJ
    Hum Mol Genet; 1999 Apr; 8(4):661-6. PubMed ID: 10072435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microsatellite instability and expression of mismatch repair genes in sporadic endometrial cancer coexisting with colorectal or breast cancer.
    Takano K; Ichikawa Y; Ueno E; Ohwada M; Suzuki M; Tsunoda H; Miwa M; Uchida K; Yoshikawa H
    Oncol Rep; 2005 Jan; 13(1):11-6. PubMed ID: 15583795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
    Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
    Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of hMSH2 and hMLH1 in colorectal carcinomas with microsatellite instability.
    Kim H; Piao Z; Kim JW; Choi JS; Kim NK; Lee JM; Park JH
    Pathol Res Pract; 1998; 194(1):3-9. PubMed ID: 9542742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
    Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
    J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of mutator phenotype in familial colorectal cancer patients not fulfilling amsterdam criteria.
    Kim JC; Lee KH; Ka IH; Koo KH; Roh SA; Kim HC; Yu CS; Kim TW; Chang HM; Gong GY; Kim JS
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6159-68. PubMed ID: 15448003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes.
    Thibodeau SN; French AJ; Roche PC; Cunningham JM; Tester DJ; Lindor NM; Moslein G; Baker SM; Liskay RM; Burgart LJ; Honchel R; Halling KC
    Cancer Res; 1996 Nov; 56(21):4836-40. PubMed ID: 8895729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.